News | March 09, 2023
Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
The only robotic-arm assisted surgical device to conduct joint replacement with accuracy and better clinical outcomes
A study by Agharkar Research Institute (ARI), Pune, has discovered that a protein secreted from intervertebral disc cells induces disc regeneration in aged degenerated discs
The two-day event focused on the multi-faceted relationship of clinical research stakeholders and looked at bridging the academic and clinical research gap.
Acquisition expands Merck’s growing hematology portfolio
Program will fight the rising incidence of antimicrobial (drug) resistance and improve patient outcomes
Kauliv provides reusable and disposable pen2 device options to cater to the global market demand.
Separate Phase 3 study evaluating 200 days of therapy with PREVYMIS in HSCT recipients at high risk of late clinically significant CMV infection recently completed, meeting its primary endpoint
Yoshindo gets exclusive commercialization rights in Japan for bUstekinumab and bDenosumab developed and manufactured by Biocon Biologics
Prime Minister said that it is a huge day for health in Gujarat and congratulated everyone associated with these projects for completing them on time.
Subscribe To Our Newsletter & Stay Updated
